Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>99% Ozagrel Sodium Powder CAS 189224-26-8

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

99% Ozagrel Sodium Powder CAS 189224-26-8

CAS NO.189224-26-8

  • Min.Order: 100 Gram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Ozagrel Sodium powder
  • Ozagrel Sodium
  • 99% Ozagrel Sodium powder

Quick Details

  • ProName: 99% Ozagrel Sodium Powder CAS 189224...
  • CasNo: 189224-26-8
  • Molecular Formula: C24H30ClN7O4S
  • Appearance: white
  • Application: anti anticoagulant
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99
  • Storage: room
  • LimitNum: 100 Gram

Superiority

 

MOQ: 1kg
Form: Powder
Colour: White
Test: HPLC
Function: anti   antiviral 
Grade: Pharm

 

Details

99%   Ozagrel Sodium Powder CAS 189224-26-8     

product Name:    Ozagrel sodium
MF:    C13H11N2NaO2
MW:    250.23
EINECS:    1806241-263-5 
Form : powder

 What is Ozagrel sodium
Ozagrel sodium is a thromboxane synthase inhibitor, which can inhibit the production of TXA2, so it has anti-platelet accumulation and vasodilation effects. Animal experiments show that intravenous administration can reduce plasma TXB levels, the Keto-PGF12/TXB2 ratio decreases, and has inhibitory effects on platelet aggregation induced by different inducers

 Ozagrel sodium function  
For the treatment of acute thrombotic cerebral infarction, subarachnoid hemorrhage after vasospasm associated with movement disorders and the improvement of symptoms complicated by cerebral ischemia.